The highly selective, potent, noncompetitive allosteric ATP inhibitor of MEK1/2 kinase—AS-703026 (pimasertib) shows promise in inhibiting tumor growth, invasion, and activation of the caspase-3-dependent apoptosis process. The gene discussed is CASP3; the disease is neoplasm.